Bionet Therapeutics (ROCO:7808) Common Stock: NT$700.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7808 Bionet Therapeutics Corp ROCO:7808
12 GF Score
Price NT$31.00
! 2 Warning Signs
View Full Analysis

What is Bionet Therapeutics Common Stock?

Bionet Therapeutics ROCO:7808 12 Common Stock is NT$700.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7808 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Bionet Therapeutics's quarterly common stock stayed the same from Dec. 2024 (NT$700.0 Mil) to Jun. 2025 (NT$700.0 Mil) and stayed the same from Jun. 2025 (NT$700.0 Mil) to Dec. 2025 (NT$700.0 Mil).

Bionet Therapeutics's annual common stock increased from Dec. 2023 (NT$450.3 Mil) to Dec. 2024 (NT$700.0 Mil) but then stayed the same from Dec. 2024 (NT$700.0 Mil) to Dec. 2025 (NT$700.0 Mil).

Bionet Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Bionet Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionet Therapeutics Common Stock Chart

Bionet Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
56.00 450.29 700.00 700.00

Bionet Therapeutics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 450.29 791.49 700.00 700.00 700.00
ROCO:7808
12GF Score
Bionet Therapeutics Corp ROCO:7808
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionet Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$700.0 Mil mean?
Bionet Therapeutics (ROCO:7808) has a Common Stock of NT$700.0 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bionet Therapeutics and its competitors.
Is Bionet Therapeutics' Common Stock too high?
Bionet Therapeutics' current Common Stock is NT$700.0 Mil. Overall, Bionet Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionet Therapeutics' Common Stock compare to VRTX and REGN?
Bionet Therapeutics' Common Stock of NT$700.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bionet Therapeutics and its competitors. Bionet Therapeutics's current Common Stock is NT$700.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionet Therapeutics stock overvalued right now?
Bionet Therapeutics (ROCO:7808) has a current Common Stock of NT$700.0 Mil. The current Common Stock is NT$700.0 Mil. Bionet Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Bionet Therapeutics (ROCO:7808), the current Common Stock is NT$700.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionet Therapeutics Business Description

Address No.28, Lane. 36 , Xinhu 1st Road, 1st Floor, Neihu District, Taipei, TWN, 11497
Bionet Therapeutics Corp is a patient-focused on regenerative medicinal products, R&D, exosomes, and gene/cell therapy biopharmaceutical company. The group develops, manufactures, and provides regenerative medicine preparations and cellular therapies to meet the evolving health needs of people at different stages of life. It focused on treatments that improve patient outcomes. It provides Cell Therapy Products and CRDMO Services.
12GF Score

Get the complete analysis for ROCO:7808

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.00
Price